Interface Biologics is a commercial stage privately held company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. IBI’s primary technology focus areas are anti-thrombogenic additives that reduce thrombosis in blood contacting medical devices and polymer enabled drug delivery devices.
View Top Employees from Interface BiologicsWebsite | http://www.interfacebiologics.com |
Revenue | $5 million |
Funding | $5 million |
Employees | 7 (4 on RocketReach) |
Founded | 2001 |
Address | Mars Centre,south Tower, 101 College Street, Suite 300, Ontario,, Toronto, Ontario M5G 1L7, CA |
Phone | (416) 673-8170 |
Fax | (416) 977-1329 |
Technologies |
JavaScript,
HTML,
Twitter
+14 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Medical Devices & Equipment, Manufacturing, Science and Engineering, Drug Delivery, Health Care, Medical Device |
Web Rank | 10 Million |
Keywords | Interface Biologics, Interface Biologics, Inc., Interfeace Biologics, Medical Device Company Toronto |
SIC | SIC Code 384 Companies, SIC Code 38 Companies |
NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular Interface Biologics employee's phone or email?
The Interface Biologics annual revenue was $5 million in 2024.
4 people are employed at Interface Biologics.
Interface Biologics is based in Toronto, Ontario.
The NAICS codes for Interface Biologics are [339, 33].
The SIC codes for Interface Biologics are [384, 38].